Veritas Announces the Sale of 3 Carbon Extractions Inc.
10 juil. 2019 17h00 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, July 10, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces that it has completed the sale of...
Veritas Announces the Completion of Clinical Trial on their Cannabis Product for Treatment of Acute Pain
15 mai 2019 08h00 HE
|
Veritas Pharma Inc.
SAN JUAN, Puerto Rico, May 15, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), is...
Veritas Pharma Enters into agreement to acquire Commercial Hemp and Cannabis Processing Facility
12 févr. 2019 09h00 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered...
Veritas Pharma Signs MOU with Santa Marta Gold Holdings for a Medical Cannabis Research Collaboration
15 janv. 2019 09h00 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered...
Veritas Pharma Enters Into Share Purchase Agreement with 3 Carbon Extractions Inc.
16 avr. 2018 07h30 HE
|
Veritas Pharma Inc.
3 Carbon is in the business of designing cannabis extraction facilities and utilizing its own proprietary extraction methods. VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) -- Veritas...
Veritas Pharma Announces Appointment of Accomplished Business Development and Strategy Professional, Justin Kausel
15 mars 2018 03h15 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, March 15, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce that Justin Kausel has...
Veritas Pharma Provides Year End Update on Company’s Activities to Shareholders
04 janv. 2018 17h24 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to provide an update to its...
Veritas Pharma Appoints of BC's "Top 40 Under 40" Robert Dawson – a Highly Regarded Marketing & Innovation Expert to Its Advisory Board
29 nov. 2017 16h30 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces the appointment of Mr. Robert “Rob”...
US Patent Office Acknowledges Provisional Patent Application for Use of Specific Cannabis Strain to Enhance Opioid Analgesia Filed by Veritas’ Research Arm Cannevert
28 nov. 2017 03h05 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces its research arm, Cannevert...
Cannevert Scientists to Present Their First Peer-Reviewed Research at December’s Prestigious British Pharmacological Society Meeting in London, UK
22 nov. 2017 16h15 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that the scientists of its research...